Sera Prognostics Inc. (NASDAQ: SERA)
$7.68
+0.6400 ( +9.09% ) 169.9K
Sera Prognostics Inc is a health diagnostic company. It develops diagnostic tests for the early prediction of a woman's individualized risk of premature birth, preeclampsia, gestational diabetes, stillbirth, and other conditions. The proprietary proteomics and bioinformatics platform of the company helps to improve maternal and neonatal health by discovering, developing, and commercializing blood-based biomarker tests, and predictive analytic products and services.
Market Data
Open
$7.68
Previous close
$7.04
Volume
169.9K
Market cap
$250.78M
Day range
$7.04 - $7.78
52 week range
$1.52 - $12.36
SEC Fillings
Form Type | Description | Pages | Date |
---|---|---|---|
10-k | Annual reports | 99 | Mar 20, 2024 |
8-k | 8K-related | 47 | Mar 20, 2024 |
4 | Insider transactions | 1 | Mar 07, 2024 |
4 | Insider transactions | 1 | Mar 07, 2024 |
4 | Insider transactions | 1 | Mar 07, 2024 |
4 | Insider transactions | 1 | Mar 07, 2024 |
4 | Insider transactions | 1 | Mar 07, 2024 |
4 | Insider transactions | 1 | Feb 07, 2024 |
4 | Insider transactions | 1 | Feb 07, 2024 |
4 | Insider transactions | 1 | Feb 07, 2024 |